"Dr Manmohan Singh, soon after becoming the prime minister, had himself carried a small table for us to have tea comfortably at his Safdarjung Lane residence instead of asking his house help," Dr Srinath Reddy, who was the chairperson of the PM's medical panel, recalled.
Be it poor, middle class, upper middle class or rich, every individual who is 70 years and above is eligible for getting Ayushman card and will receive free treatment up to Rs 5 lakh at any of the AB PMJAY empanelled hospitals once the expanded scheme gets launched.
The cross-sectional survey was conducted among 1,566 healthcare workers from diverse medical institutions across India using a pre-tested, self-administered online questionnaire, which assessed various dimensions of workplace safety.
The National Medical Commission (NMC) has initiated the process of registration of all MBBS doctors eligible to practice in India on a recently launched portal, as a part of which all medical practitioners will have a unique ID.
With poll fever gathering steam, business is booming for New Delhi's detective agencies as politicians, especially aspiring candidates, are hiring private eyes to spy on their rivals and even colleagues.
Medical education regulator NMC recently notified the "Post-Graduate Medical Education Regulations, 2023" according to which all rounds of counselling for all PG seats will be held online mode by state or central counselling authorities.
All doctors must prescribe generic drugs, failing which they will be penalised and even their license to practice may also be suspended for a period, according to the new regulations issued by the National Medical Commission (NMC).
The renowned pulmonologist, who was part of the national COVID task force, highlighted the need for research on developing vaccines which will cover not only the current circulating strains but also from the emerging variants.
As India witnessed the highest number of Covid cases in over four months, former All India Institute of Medical Sciences (AIIMS) director Dr Randeep Guleria on Wednesday said the new XBB.1.16 variant could be driving the recent rise but emphasised there was no need for panic as long it does not cause severe illness and deaths.
Dr Malhotra, who has demanded a full safety review into the use of AstraZeneca's Covid vaccine, told PTI Covishield "should never have been rolled out in the country in the first place".
The current Covid situation in India is under control and there are no reasons to panic, said Dr N K Arora, the chairperson of National Technical Advisory Group on Immunization (NTAGI).
The first case of BF.7 in India was detected in October by Gujarat Biotechnology Research Centre.
It is feared that data of around 3-4 crore patients could have been compromised due to the breach detected Wednesday morning.
According to some experts, there is not much difference in the number of seasonal flu cases and that of COVID-19, even though they stressed that surveillance for newer variants should continue in the off chance of a new lineage of coronavirus catching the country off guard.
The government's Covid vaccination programme is in its final leg with the health ministry deciding against procuring more vaccines as of now and surrendering Rs 4,237 crore, or nearly 85 per cent of the 2022-23 budget allocation for inoculation purposes, to the finance ministry.
The man had attended a stag party recently in Manali in Himachal Pradesh.
According to these experts, a monkeypox outbreak can effectively be tackled by strong surveillance.
So far, less than 1 per cent of the target population of 77 crore in the 18-59 age group have been administered the precaution dose.
The DCGI's nod came after the subject expert committee on COVID-19 of the CSDCO last week recommended granting emergency use authorisation to Covovax for the age group of 7 to 11 years.
The tenure of the incumbent AIIMS director, Dr Randeep Guleria, which was set to end on March 24, was extended by three months.
© 2025 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances